What is the use of letrozole tablet?

Letrozole tablets are used to lower estrogen levels in the body. They are commonly prescribed for hormone-related conditions and to stimulate ovulation in women trying to conceive.

How does letrozole help you get pregnant?

Letrozole helps pregnancy by reducing estrogen levels, which increases follicle-stimulating hormone (FSH). This stimulates the ovaries to mature and release an egg during ovulation.

What happens after taking letrozole for 5 days?

After taking letrozole for five days, ovarian follicles begin developing. Ovulation usually occurs within 5-10 days after finishing the course, depending on hormonal response.

What are the side effects of letrozole?

Common side effects of letrozole include headache, dizziness, fatigue, hot flashes, nausea, and joint pain. Most symptoms are mild and temporary.

What happens to your body after taking letrozole?

Letrozole reduces estrogen production. The body compensates by increasing reproductive hormones, which can stimulate ovulation and alter hormonal balance temporarily.

Letrozole Tablets (CAS 112809-51-5) - FEMANOVA by NovaTech Sciences

Name: Letrozole
Brand: Nova Techsciences
SKU: letrozole

Quick Facts

Form

Oral tablets

Active Ingredient

Letrozole

CAS Number

112809-51-5

Strength

2.5 mg Letrozole per tablet

Indication

What is Letrozole (CAS 112809-51-5)?Mechanism of Action - Aromatase InhibitionKey Benefits of Letrozole CAS 112809-51-5Effective aromatase inhibitionReliable estrogen suppressionControlled hormone balance support

FEMANOVA Tablets by NovaTech Sciences are formulated with high-quality Letrozole (CAS 112809-51-5), a well-established aromatase inhibitor known for its precise estrogen suppression properties. Recognized globally in pharmaceutical applications, Letrozole CAS 112809-51-5 plays a critical role in reducing estrogen production by inhibiting the aromatase enzyme responsible for converting androgens into estrogen.

What is Letrozole (CAS 112809-51-5)?

Letrozole, identified by CAS 112809-51-5, is a non-steroidal aromatase inhibitor widely used for estrogen control and hormone modulation. The CAS registry number 112809-51-5 ensures chemical accuracy, traceability, and standardized identification across pharmaceutical and research industries.

By targeting the aromatase enzyme, Letrozole CAS 112809-51-5 helps regulate estrogen levels effectively, supporting balanced hormonal environments. Its mechanism of action makes it a trusted compound in estrogen management protocols.

Mechanism of Action - Aromatase Inhibition

The primary function of Letrozole (CAS 112809-51-5) is aromatase inhibition. Aromatase is the enzyme responsible for converting testosterone and other androgens into estrogen. By blocking this enzyme, Letrozole CAS 112809-51-5 reduces estrogen synthesis at the source.

This targeted approach allows for controlled estrogen suppression without directly interfering with androgen receptors. As a result, Letrozole (CAS 112809-51-5) supports precise hormonal modulation and balance.

Key Benefits of Letrozole CAS 112809-51-5

Effective aromatase inhibition

Reliable estrogen suppression

Controlled hormone balance support

Verified identity through CAS 112809-51-5

High manufacturing quality standards

By maintaining strict quality control measures, NovaTech Sciences ensures that Letrozole CAS 112809-51-5 in FEMANOVA Tablets meets professional standards for purity and consistency.

Why Choose FEMANOVA by NovaTech Sciences?

NovaTech Sciences prioritizes pharmaceutical precision and product reliability. Each batch of Letrozole (CAS 112809-51-5) undergoes quality verification to ensure identity, consistency, and compliance with established standards.

FEMANOVA Tablets are manufactured using advanced production protocols designed to preserve the integrity of Letrozole CAS 112809-51-5. This guarantees that every tablet delivers accurate dosing and dependable aromatase inhibition performance.

Quality, Traceability & Chemical Identification

The presence of CAS 112809-51-5 confirms the exact chemical identity of Letrozole used in FEMANOVA. CAS numbers are globally recognized identifiers that eliminate confusion and ensure pharmaceutical accuracy. By clearly specifying Letrozole CAS 112809-51-5, NovaTech Sciences provides transparency and confidence in product authenticity.

Consistent Hormonal Support

Through effective aromatase inhibition, Letrozole (CAS 112809-51-5) supports hormone balance management by reducing estrogen production. Its selective action makes it one of the most widely recognized compounds for estrogen suppression strategies.

FEMANOVA offers a dependable formulation of Letrozole CAS 112809-51-5, designed for consistent performance and stability.

Conclusion

If you are looking for a trusted formulation of Letrozole (CAS 112809-51-5), FEMANOVA Tablets by NovaTech Sciences deliver pharmaceutical-grade aromatase inhibition with verified chemical identification. With strong emphasis on quality control, purity, and standardized identification through CAS 112809-51-5, FEMANOVA ensures reliable estrogen suppression and effective hormone balance support.

Safety Information

Precautions

Always consult your healthcare provider before using FEMANOVA (Letrozole 2.5 mg). This aromatase inhibitor is potent and should be used only under proper medical guidance, especially when used for hormone regulation, estrogen control, or post-cycle therapy.
Use FEMANOVA exactly as prescribed to avoid hormonal imbalance.
Regular blood tests are recommended to monitor estrogen suppression levels.
Inform your doctor if you are taking any hormone-based medicines, steroids, or fertility treatments.
Take the medicine at the same time each day for stable estrogen regulation.
Avoid alcohol or substances that may interfere with estrogen-control therapy.
Store in a cool, dry place away from direct sunlight.

Contraindications

Do not use if you are allergic to Letrozole or any inactive ingredient in FEMANOVA.
Not recommended for pregnant or breastfeeding women due to strong estrogen suppression.
Avoid use in individuals with severe liver disease unless advised by a specialist.
Not suitable for premenopausal women unless used under strict medical monitoring.
Stop using immediately and seek medical attention if you experience unusual side effects.

Indication